Us Bancorp \De\ Sutro Biopharma, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 53 shares of STRO stock, worth $98. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 12,000 99.56%

Holding current value

$98

Previous $35,000 100.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$2.88 - $5.01 $34,407 - $59,854	-11,947 Reduced 99.56%	53 $0
Q2 2024 Aug 06, 2024	SELL	$2.92 - $5.33 $14,600 - $26,650	-5,000 Reduced 29.41%	12,000 $35,000
Q1 2024 May 07, 2024	BUY	$3.27 - $5.65 $55,590 - $96,050	17,000 New	17,000 $96,000
Q2 2022 Aug 01, 2022	SELL	$3.41 - $8.95 $2,519 - $6,614	-739 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.78 - $15.31 $4,138 - $8,144	532 Added 257.0%	739 $6,000
Q4 2021 Feb 11, 2022	SELL	$14.25 - $23.53 $8,934 - $14,753	-627 Reduced 75.18%	207 $3,000
Q3 2021 Nov 10, 2021	BUY	$16.88 - $22.38 $14,077 - $18,664	834 New	834 $16,000

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $96.5M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account